Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 879 of 5804
-
New pill could help shed pounds without surgery
Disease control Not yet recruitingThis is a multicenter, randomized, double-blind, placebo-controlled, phase III clinical study to evaluate the efficacy and safety of the oral small molecule MDR-001 Tablets over 52 weeks as an adjunct to a lifestyle intervention in participants with overweight or obesity.The goal…
Phase: PHASE3 • Sponsor: MindRank AI Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could thousands of breast cancer patients skip extra radiation?
Disease control Not yet recruitingThe research hypothesis is that the tumor-free survival rate of intermediate-risk breast cancer patients exempted from RNI is not inferior to that of those receiving RNI. Patients with intermediate-risk breast cancer have a relatively low local-regional recurrence rate whether th…
Phase: PHASE3 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Could a diabetes drug ease brain pressure?
Disease control Not yet recruitingThis will be a randomized, double-blind, parallel, placebo-controlled trial of 60 participants. The primary analysis will be a statistical comparison of the estimates of the mean difference in the 12-month change in intracranial pressure (ICP) between participants assigned to the…
Phase: PHASE4 • Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Supercharged T-Cells take on Hard-to-Treat cancers
Disease control Not yet recruitingThis is a single-arm, Multicenter, open-label clinical study aimed at evaluating the safety and efficacy of TCR-T injection in patients with advanced solid tumors induced by KRAS mutations.
Phase: EARLY_PHASE1 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Ambulance blood test could speed up stroke care
Diagnosis Not yet recruitingAs an investigator-initiated and conducted, multi-centre, open-label, single-arm prospective observational trial, INTERACT4 Expansion aims to evaluate the diagnostic accuracy of GFAP measured using a point-of-care device, for identifying ICH in participants presenting with acute …
Sponsor: The George Institute • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
Ancient herb mix takes on brain bleed: can it stop repeat strokes?
Disease control Recruiting nowCerebral hemorrhage, as a serious cerebrovascular disease, has the highest disability rate and mortality rate among all types of cerebrovascular diseases .It has brought a heavy burden to society. In China, the incidence of cerebral hemorrhage is much higher than that in Europe a…
Phase: PHASE3 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for Hard-to-Treat breast cancer: experimental drug MR001 enters human trials
Disease control Recruiting nowThis Phase Ib/IIa study is evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of MR001 in patients with advanced triple-negative breast cancer (TNBC) who have progressed after prior therapy.
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Majory Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can a multiple sclerosis drug help preserve insulin production in type 1 diabetes?
Disease control Recruiting nowPurpose of the Clinical Trial: This clinical trial aims to investigate whether dimethyl fumarate can treat adults with newly diagnosed type 1 diabetes and to evaluate the safety profile of dimethyl fumarate. Primary Research Questions: Does dimethyl fumarate protect pancreatic…
Phase: PHASE3 • Sponsor: Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New vaccine aims to block HPV cancers missed by current shots
⭐️ VACCINE ⭐️ Recruiting nowThis phase I trial tests the safety, side effects, and best dose of RG1-virus-like particle (VLP) in preventing human papillomavirus (HPV)-related cancers in women. RG1-VLP is a vaccine that aims to protect against rare HPV types not targeted by currently approved HPV vaccines. H…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 14:02 UTC
-
New 3-Week radiation plan aims to cut side effects for sarcoma patients
Disease control Recruiting nowThe purpose of the study is to investigate whether a personalized selection of patients with localized soft tissue sarcoma for preoperative proton radiation therapy can reduce long-term radiation side effects without increasing surgical complications or reducing the effectiveness…
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Hip replacement vs. screws: which gets seniors back on their feet faster?
Disease control Recruiting nowThis study is an intervention domain of the Musculoskeletal Adaptive Platform Trial. The primary goal of this pragmatic, randomized, open-label, comparative effectiveness trial is to evaluate if arthroplasty is superior to internal fixation when used to treat minimally displaced …
Phase: NA • Sponsor: University of Southern California • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New antibiotic combo takes on deadly hospital pneumonia
Disease control Recruiting nowThis study is to evaluate the efficacy and safety of Meropenem and Pralurbactam for Injection in Subjects with HABP/VABP. The primary objective is to demonstrate non-inferiority of Meropenem and Pralurbactam to Ceftazidime and Avibactam Sodium for Injection. This study is a rando…
Phase: PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Weekly shot could replace daily growth hormone for short kids born small
Disease control Recruiting nowThis is a multicenter, randomized, open-label, active-controlled Phase III clinical trial to evaluate the efficacy and safety of Inpegsomatropin injection,once a week,compared with recombinant human growth hormone (rhGH) in children with short stature born small for gestational a…
Phase: PHASE3 • Sponsor: Xiamen Amoytop Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
VR exergames in school recess: a new weapon against childhood obesity?
Disease control ENROLLING_BY_INVITATIONChildhood overweight and obesity are major public health concerns associated with increased cardiometabolic risk and reduced quality of life. In Galicia (Spain), approximately one-third of schoolchildren aged 7-15 years are affected. Physical inactivity and sedentary behaviors co…
Phase: NA • Sponsor: University of Vigo • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New diagnostic tool could speed up treatment for deadly heart infection
Diagnosis Recruiting nowThe goal of this study is to evaluate the impact of a diagnostic algorithm combining culture-based and molecular methods on the frequency of etiotropic antibiotic therapy prescription within 14 days of diagnosis of infective endocarditis
Phase: NA • Sponsor: I.M. Sechenov First Moscow State Medical University • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC
-
New drug SKB571 targets advanced lung cancer in Mid-Stage trial
Disease control Recruiting nowThis is a multicenter, phase II study. The purpose of this study is to evaluate the safety and preliminary anti-tumor activity of SKB571 in patients with advanced non-small cell lung cancer. Eligible subjects will receive SKB571 monotherapy, until radiographic disease progression…
Phase: PHASE2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Vaginal fluid may hold key to early cancer detection
Diagnosis Recruiting nowThis study will investigate vaginal secretions in those patients with cancer versus those who are cancer free and compare changes in specific markers that change when a cancer first develops. Patients who are being investigated for any gynaecological cancer, undergoing surgery t…
Sponsor: University Hospital Southampton NHS Foundation Trust • Aim: Diagnosis
Last updated Jun 27, 2026 13:01 UTC
-
A 15-minute video call after surgery may stop chronic pain in opioid users
Prevention Recruiting nowChronic opioid users undergoing surgery are at increased risk of CPSP, contributing to long-term disability, decreased quality of life, and prolonged opioid exposure. Existing preventive strategies remain limited, and early postoperative monitoring may represent a key opportunity…
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Prevention
Last updated Jul 23, 2026 00:00 UTC
-
Heart fix may stop migraines: new trial tests Hole-Closing procedure
Symptom relief Recruiting nowPatent Foramen Ovale (PFO) is a common congenital heart defect. Recent studies have suggested a potential association between PFO and migraines, particularly migraine with aura. It is hypothesized that PFO may allow microemboli or vasoactive substances from venous blood to bypass…
Phase: NA • Sponsor: First Affiliated Hospital Xi'an Jiaotong University • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Custom Gene-Targeting drug tested in single child with rare brain disease
Disease control OngoingThis study is being conducted to evaluate individualised antisense oligonucleotides (ASOs) in participants with severely debilitating, life threatening (SDLT) central nervous system (CNS) conditions caused by unique genetic variants amenable to correction by an ASO.
Phase: PHASE1, PHASE2 • Sponsor: EveryONE Medicines Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC